As Zimmer focuses on escalating its compliance activities, concerns over the loss of physician customers due to disruptions in its orthopedic unit have negatively impacted the company’s overall performance, a company official said.

Kickback lawsuits, a manufacturing halt of its orthopedic surgical products and a temporary suspension of its Durom Cup sales have plagued Zimmer over the past year.

As a result, the company lost a high volume of surgeons who also served as consultants — customers it does not expect to regain, CEO David Dvorak said during the company’s third-quarter earnings call last month.

SOURCE: FDA NEWS